The 10 BILLION$ OTC company in SIGY's NR is TorayThe filtration crowd is a small, dare I say an "intimate group". Bear in mind, we chose to have the "medical adviser to CTSO" sit on our DSMB ( data safety monitoring board ) for our FDA phase III Euphuctus Trial. Furtherhore, in mid August while our data-room was still "under renovation" ( AKA deep data diving ), CTSO announced / introduced the Sorb XL. The XL was said to make the PMX "obsolete" and apparently absorbed both cytokines and endotoxin, a multi-tasking 4 door sedan available in an array of colors ; - ) It gets better...just a year after said "XL" was released, it was the primary focal point of the EDTXF AGM Q&A session...how nice: - )
In their previous release SIGY spoke of EDTXF, now just some obscure 10 BILL company counting on a little Canadien group to get them across the Finnish line...speaking of Scandinavia, I found a cute little Island in Norway that a poster friend of ours chose to base his handle on.
Looks like us Yanks ( slow jerks as per definition ) aren't overly impressed with the EDTXF and the entire 32 penny OTC profile....that's a shame....
I am curious about the entire University Health Network up in Toronto...they are the hosts of Gerbel's Thera-laced trial at Princess Margaret and it too has rocks in it share price shoes ; - ) What up Canada? Pumping / priming the wrongo pump are we? Should we stay focussed on Hemosol - Prometic - Bioniche - Concordia - Blu-us - Sona - Medmira - Tekmira or a large selection of other "offerings" that appear to leave Canadien's a little "light on the loonie"?
Tommy - AKA every intelligent factual poster ; - )
PS - I am still counting 2020 to serve as our "launch point"...just waiting for the poker chips to get doled out..maybe the chips were on Gino's 18 wheeler that flipped over with all the Bio-vale records ; - )